International Association for the Study of Lung Cancer names new CEO

The International Association for the Study of Lung Cancer announced Dave Mesko is now serving as its CEO, responsible for the overall operation of the organization.

Mesko replaced Fred R. Hirsch, MD, PhD, whose 5-year term as CEO of the International Association for the Study of Lung Cancer (IASLC) ended in October.

Mesko — who previously served as chief operating officer at the Council on Foundations and the chief financial officer at Georgetown University School of Nursing and Health Studies — joined the IASLC in February as managing director.

“Dave Mesko brings a wealth of management experience to the IASLC at a time when the organization is experiencing unprecedented growth,” Giorgio V. Scagliotti, MD, PhD, president of the IASLC Board of Directors, said in a press release. “Dave’s promotion recognizes that, while the IASLC remains committed to maintaining its scientific leadership as the only global organization dedicated solely to the study of thoracic malignancies, the association also needs a CEO well-versed in the management, finance, strategy and processes that organizations need to run effectively and to thrive in the 21st century.”

The IASLC also announced it will restructure to enhance the experience for its members — with more details expected in January — while maintaining its key initiatives, mission and commitment to science.

“The progress both in lung cancer and at the IASLC is exciting. We are poised for growth, and I look forward to honoring the mission of the IASLC while enhancing our member experience and our strategic focus,” Mesko said in the release. “I share the passion of our members, partners and staff in collaborating across borders and disciplines to conquer thoracic cancers worldwide.”